CD83 and neoplasm: In contrast, the CD209+ CD83− NTLS-DC subpopulation has an immunosuppressive phenotype and develops under the stimulation of various tumor-derived factors, including IL-10, TGF-β, prostaglandin E2 (PGE2), and chemokines (44).